UCSF Center for Tuberculosis

Tuberculosis (TB) is a leading cause of death worldwide from a single infectious agent, now ranking above HIV/AIDS and COVID-19.

Explore what UCSF is doing to combat tuberculosis.

Immunology & Bench Science

Data Science

Epidemiology & Public Health

Therapeutics, Trials & Pharmacokinetics

Diagnostics & Biomarker Discovery

Implementation Science

Education & Assistance

Policy & Guidelines

Clinical Sciences

Mission: Improving the lives of TB patients worldwide through the training of the next generation of scientists and the acceleration of advances in tuberculosis research, practice, and policy.

Learn more about the Center for TB

Leadership

Babak Javid, MB, PhD

Co-Director, UCSF Center for Tuberculosis

M_MED-ZSFG-EXPM

Dr. Javid is a physician-scientist, Wellcome Trust Investigator and Associate Professor in the Division of Experimental Medicine at UCSF. His research focuses on fundamental mycobacterial pathophysiology, regulation of adaptive protein synthesis, molecular mechanisms of antibiotic tolerance and human humoral immunity to tuberculosis. He went to medical school at the University of Cambridge, and after residency in general (internal) medicine returned to Cambridge to study for a PhD in immunobiology as an MRC training fellow. Following fellowship in infectious diseases, Dr.

Rada Savic, PhD

Co-Director, UCSF Center for Tuberculosis

P_Bioengineering

With an emphasis on TB therapeutics, my research uses computational methods to study the dynamic interplay between disease progression, drug and biomarker response across relevant scales (molecule, cell, tissue, organ & whole body) in order to determine causal links underlying variability in (safety and efficacy) clinical outcomes.

Elizabeth Fair, PhD, MPH

Co-Director, UCSF Center for Tuberculosis

M_MED-ZSFG-PULM

My research is focused on tuberculosis (TB), TB/HIV, global health, and implementation research. Active projects include evaluating the feasibility, yield, and cost-effectiveness of TB contact investigation in Tanzania; exploring TB-associated stigma in Bangladesh; evaluating innovative technologies for TB education and control in Madagascar; and implementing active TB case finding strategies in Mozambique. I serve as a regular consultant for the American Thoracic Society (ATS), World Health Organization (WHO), and the Dutch Tuberculosis Group (KNCV).